Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

155 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Randomized phase III study of 1 month versus 1 year of adjuvant high-dose interferon alfa-2b in patients with resected high-risk melanoma.
Pectasides D, Dafni U, Bafaloukos D, Skarlos D, Polyzos A, Tsoutsos D, Kalofonos H, Fountzilas G, Panagiotou P, Kokkalis G, Papadopoulos O, Castana O, Papadopoulos S, Stavrinidis E, Vourli G, Ioannovich J, Gogas H. Pectasides D, et al. Among authors: papadopoulos s, papadopoulos o. J Clin Oncol. 2009 Feb 20;27(6):939-44. doi: 10.1200/JCO.2008.16.3121. Epub 2009 Jan 12. J Clin Oncol. 2009. PMID: 19139440 Clinical Trial.
Temozolomide in combination with celecoxib in patients with advanced melanoma. A phase II study of the Hellenic Cooperative Oncology Group.
Gogas H, Polyzos A, Stavrinidis I, Frangia K, Tsoutsos D, Panagiotou P, Markopoulos C, Papadopoulos O, Pectasides D, Mantzourani M, Middleton M, Vaiopoulos G, Fountzilas G. Gogas H, et al. Among authors: papadopoulos o. Ann Oncol. 2006 Dec;17(12):1835-41. doi: 10.1093/annonc/mdl311. Epub 2006 Sep 15. Ann Oncol. 2006. PMID: 16980601 Free article. Clinical Trial.
p53 codon 72 Pro homozygosity increases the risk of cutaneous melanoma in individuals with dark skin complexion and among noncarriers of melanocortin 1 receptor red hair variants.
Stefanaki I, Stratigos AJ, Dimisianos G, Nikolaou V, Papadopoulos O, Polydorou D, Gogas H, Tsoutsos D, Panagiotou P, Kanavakis E, Antoniou C, Katsambas AD. Stefanaki I, et al. Among authors: papadopoulos o. Br J Dermatol. 2007 Feb;156(2):357-62. doi: 10.1111/j.1365-2133.2006.07645.x. Br J Dermatol. 2007. PMID: 17223878
Risk associations of melanoma in a Southern European population: results of a case/control study.
Nikolaou VA, Sypsa V, Stefanaki I, Gogas H, Papadopoulos O, Polydorou D, Plaka M, Tsoutsos D, Dimou A, Mourtzoukou E, Korfitis V, Hatziolou E, Antoniou C, Hatzakis A, Katsambas A, Stratigos AJ. Nikolaou VA, et al. Among authors: papadopoulos o. Cancer Causes Control. 2008 Sep;19(7):671-9. doi: 10.1007/s10552-008-9130-0. Epub 2008 Feb 29. Cancer Causes Control. 2008. PMID: 18307049
Paclitaxel-ifosfamide-cisplatin as salvage chemotherapy in ovarian cancer patients pretreated with platinum compounds and paclitaxel.
Polyzos A, Kosmas C, Tsavaris N, Toufexi H, Lagadas A, Gogas H, Giannakopoulos K, Kouraklis G, Griniatsos J, Felekouras E, Tsigris C, Nikiteas N, Papadopoulos O, Giannopoulos A. Polyzos A, et al. Among authors: papadopoulos o. Anticancer Res. 2007 May-Jun;27(3B):1645-51. Anticancer Res. 2007. PMID: 17595790 Free article. Clinical Trial.
Melanocortin receptor-1 gene polymorphisms and the risk of cutaneous melanoma in a low-risk southern European population.
Stratigos AJ, Dimisianos G, Nikolaou V, Poulou M, Sypsa V, Stefanaki I, Papadopoulos O, Polydorou D, Plaka M, Christofidou E, Gogas H, Tsoutsos D, Kastana O, Antoniou C, Hatzakis A, Kanavakis E, Katsambas AD. Stratigos AJ, et al. Among authors: papadopoulos o. J Invest Dermatol. 2006 Aug;126(8):1842-9. doi: 10.1038/sj.jid.5700292. Epub 2006 Apr 6. J Invest Dermatol. 2006. PMID: 16601669 Free article.
155 results